Bolt Biotherapeutics
Stock Forecast, Prediction & Price Target
Bolt Biotherapeutics Financial Estimates
Bolt Biotherapeutics Revenue Estimates
Bolt Biotherapeutics EBITDA Estimates
Bolt Biotherapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.26M N/A | $5.72M 354.68% | $7.87M 37.47% | Avg: $3.48M Low: $683.62K High: $7.49M avg. -55.76% | Avg: $15.51M Low: $7.86M High: $24.71M avg. 345.32% | Avg: $20.05M Low: $10.16M High: $31.94M avg. 29.22% | Avg: $50M Low: $25.35M High: $79.65M avg. 149.37% |
Net Income
% change YoY
| $-104.39M N/A | $-85.87M 17.73% | $-69.19M 19.42% | Avg: $-47.01M Low: $-59.74M High: $-27.98M avg. 32.06% | Avg: $-48.81M Low: $-62.01M High: $-24.95M avg. -3.82% | Avg: $-21.04M Low: $-37.27M High: $-7.56M avg. 56.87% | Avg: $-4.72M Low: $-8.37M High: $-1.69M avg. 77.54% |
EBITDA
% change YoY
| $-85.51M N/A | $-88.65M -3.67% | $-74.34M 16.14% | Avg: $-3.48M Low: $-7.49M High: $-683.62K avg. 95.31% | Avg: $-15.51M Low: $-24.71M High: $-7.86M avg. -345.32% | Avg: $-20.05M Low: $-31.94M High: $-10.16M avg. -29.22% | Avg: $-50M Low: $-79.65M High: $-25.35M avg. -149.37% |
EPS
% change YoY
| -$2.79 N/A | -$2.3 17.56% | -$1.83 20.43% | Avg: -$1.07 Low: -$1.58 High: -$0.74 avg. 41.53% | Avg: -$1.04 Low: -$1.64 High: -$0.66 avg. 3.03% | Avg: -$0.56 Low: -$0.99 High: -$0.2 avg. 46.34% | Avg: -$0.13 Low: -$0.22 High: -$0.04 avg. 77.54% |
Operating Expenses
% change YoY
| $94.04M N/A | $96.05M 2.12% | $84.07M -12.47% | Avg: $59.06M Low: $11.58M High: $127.07M avg. -29.74% | Avg: $263.03M Low: $133.39M High: $419.04M avg. 345.32% | Avg: $339.91M Low: $172.37M High: $541.50M avg. 29.22% | Avg: $847.65M Low: $429.87M High: $1.35B avg. 149.37% |
FAQ
What is Bolt Biotherapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 40.66% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -59.74M, average is -47.01M and high is -27.98M.
What is Bolt Biotherapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 117.04% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $683.62K, average is $3.48M and high is $7.49M.
What is Bolt Biotherapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 42.11% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$1.58, average is -$1.07 and high is $-0.74.